1. Home
  2. Labeler Index
  3. Wg Critical Care, Llc
  4. 44567-100
  5. NDC Package Code: 44567-100-10 Ampicillin

NDC Package 44567-100-10 Ampicillin

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory .

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
44567-100-10
Package Description:
10 VIAL in 1 TRAY / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product Code:
44567-100
Proprietary Name:
Ampicillin
Usage Information:
Ampicillin for Injection, USP is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: Respiratory Tract Infections caused by S. pneumoniae, Staphylococcus aureus (penicillinase and non-penicillinase producing), H. influenzae and Group A beta-hemolytic Streptococci.Bacterial Meningitis caused by E. coli, Group B Streptococci, and other Gram-negative bacteria (Listeria monocytogenes, N. meningitidis). The addition of an aminoglycoside with ampicillin may increase its effectiveness against Gram-negative bacteria.Septicemia and Endocarditis caused by susceptible Gram-positive organisms including Streptococcus spp., penicillin-G-susceptible staphylococci and enterococci. Gram-negative sepsis caused by E. coli, Proteus mirabilis and Salmonella spp. responds to ampicillin. Endocarditis due to enterococcal strains usually respond to intravenous therapy. The addition of an aminoglycoside may enhance the effectiveness of ampicillin when treating streptococcal endocarditis.Urinary Tract Infections caused by sensitive strains of E. coli and Proteus mirabilis.Gastrointestinal Infections caused by Salmonella typhi (typhoid fever), other Salmonella spp. and Shigella spp. (dysentery) usually respond to oral or intravenous therapy.Bacteriology studies to determine the causative organisms and their susceptibility to ampicillin should be performed. Therapy may be instituted prior to obtaining results of susceptibility testing. It is advisable to reserve the parenteral form of this drug for moderately severe and severe infections and for patients who are unable to take the oral forms. A change to oral ampicillin may be made as soon as appropriate. Indicated surgical procedures should be performed.To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ampicillin for Injection, USP and other antibacterial drugs, Ampicillin for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
11-Digit NDC Billing Format:
44567010010
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
10 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1721473 - ampicillin 250 MG Injection
  • RxCUI: 1721473 - ampicillin (as ampicillin sodium) 250 MG Injection
  • RxCUI: 1721474 - ampicillin 500 MG Injection
  • RxCUI: 1721474 - ampicillin (as ampicillin sodium) 500 MG Injection
  • RxCUI: 1721475 - ampicillin 1 GM Injection
    • Labeler Name:
    Wg Critical Care, Llc
    Sample Package:
    No
    FDA Application Number:
    ANDA062772
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    05-10-2012
    End Marketing Date:
    03-31-2016
    Listing Expiration Date:
    03-31-2016
    Exclude Flag:
    D
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 44567-100-10?

    The NDC Packaged Code 44567-100-10 is assigned to a package of 10 vial in 1 tray / 1 injection, powder, for solution in 1 vial of Ampicillin, labeled by Wg Critical Care, Llc. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package.

    Is NDC 44567-100 included in the NDC Directory?

    The product was first marketed by Wg Critical Care, Llc on May 10, 2012 and its listing in the NDC Directory is set to expire on March 31, 2016 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 44567-100-10?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 10.

    What is the 11-digit format for NDC 44567-100-10?

    The 11-digit format is 44567010010. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-244567-100-105-4-244567-0100-10